These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9042907)

  • 1. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
    Serova OM; Mazoyer S; Puget N; Dubois V; Tonin P; Shugart YY; Goldgar D; Narod SA; Lynch HT; Lenoir GM
    Am J Hum Genet; 1997 Mar; 60(3):486-95. PubMed ID: 9042907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
    Ganguly T; Dhulipala R; Godmilow L; Ganguly A
    Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
    Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
    Håkansson S; Johannsson O; Johansson U; Sellberg G; Loman N; Gerdes AM; Holmberg E; Dahl N; Pandis N; Kristoffersson U; Olsson H; Borg A
    Am J Hum Genet; 1997 May; 60(5):1068-78. PubMed ID: 9150154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
    Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
    Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
    J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
    Rebbeck TR; Couch FJ; Kant J; Calzone K; DeShano M; Peng Y; Chen K; Garber JE; Weber BL
    Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer.
    Balci A; Huusko P; Pääkkönen K; Launonen V; Uner A; Ekmekçi A; Winqvist R
    Eur J Cancer; 1999 May; 35(5):707-10. PubMed ID: 10505028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
    Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI
    Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
    Schubert EL; Lee MK; Mefford HC; Argonza RH; Morrow JE; Hull J; Dann JL; King MC
    Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
    Essioux L; Girodet C; Sinilnikova O; Pagès S; Eisinger F; de Résende S; Maugard C; Lanoë D; Longy M; Bignon YJ; Sobol H; Bonaïti-Pellié C; Stoppa-Lyonnet D
    Am J Med Genet; 1998 Sep; 79(3):175-83. PubMed ID: 9788557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
    Tonin PN; Mes-Masson AM; Futreal PA; Morgan K; Mahon M; Foulkes WD; Cole DE; Provencher D; Ghadirian P; Narod SA
    Am J Hum Genet; 1998 Nov; 63(5):1341-51. PubMed ID: 9792861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.
    Cui J; Antoniou AC; Dite GS; Southey MC; Venter DJ; Easton DF; Giles GG; McCredie MR; Hopper JL
    Am J Hum Genet; 2001 Feb; 68(2):420-31. PubMed ID: 11133358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
    Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
    J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.